Ask a Question

User pointroof52

Member for: 6 days (since Jul 7)
Type: Registered user
Full name:
Location:
About: Corrigendum re "Docetaxel Vs . Surveillance Soon after Revolutionary Radiotherapy for Intermediate- or perhaps High-risk Men's prostate Cancer-Results through the Prospective, Randomised, Open-label Phase 3 SPCG-13 Trial" [Eur Urol 2019;Seventy-six:823-30]

Activity by pointroof52

Score: 0 points
Title: Newbie
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for pointroof52

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...